COMP <GO>
PGEN vs NAMS // RETURN ON INVESTED CAPITAL (ROIC)
Precigen Inc. (NASDAQ) VS. NewAmsterdam Pharma Company N.V. (NASDAQ) • 15-METRIC TALLY: PGEN 3
— NAMS 1
■ METRIC PARITY
LAST: $6.64 (+9.21%) • MKT CAP: $2.38B
roic
-35.00%
LAST: $20.76 (-1.47%) • MKT CAP: $2.48B
roic
-35.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PGEN VS. NAMS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PGEN | NAMS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -3.78% | -5.96% | +2.18 | PGEN | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 146.70% | -50.60% | +197.30 | PGEN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 15.94 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 3/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.3 | 40.7 | +9.58 | PGEN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.38B | $2.48B | -$104.2M | NAMS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PGEN REV | NAMS REV | PGEN GROSS % | NAMS GROSS % | PGEN FCF | NAMS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $9.7M | $22.5M | — | — | -$89.8M | -$147.8M |
| FY 2024 | $3.9M | $45.6M | — | — | -$76.8M | -$158.6M |
| FY 2023 | $6.2M | $14.1M | — | — | -$66.9M | -$141.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PGEN // BETA —
NAMS // BETA —